TY  - GEN
AU  - Mayes,Patrick A
AU  - Dolloff,Nathan G
AU  - Daniel,Colin J
AU  - Liu,J Judy
AU  - Hart,Lori S
AU  - Kuribayashi,Kageaki
AU  - Allen,Joshua E
AU  - Jee,David I H
AU  - Dorsey,Jay F
AU  - Liu,Yingqiu Y
AU  - Dicker,David T
AU  - Brown,J Martin
AU  - Furth,Emma E
AU  - Klein,Peter S
AU  - Sears,Rosalie C
AU  - El-Deiry,Wafik S
TI  - Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1
SN  - 1538-7445
PY  - 2011///1003
KW  - Adenocarcinoma
KW  - blood supply
KW  - Angiogenesis Inhibitors
KW  - pharmacology
KW  - Animals
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - drug effects
KW  - CDC2 Protein Kinase
KW  - antagonists & inhibitors
KW  - Camptothecin
KW  - analogs & derivatives
KW  - Cell Hypoxia
KW  - Cell Line, Tumor
KW  - Colonic Neoplasms
KW  - Drug Synergism
KW  - Fluorouracil
KW  - Gene Expression Regulation, Neoplastic
KW  - Glycogen Synthase Kinase 3
KW  - Glycogen Synthase Kinase 3 beta
KW  - Humans
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - Inhibitor of Apoptosis Proteins
KW  - physiology
KW  - Irinotecan
KW  - Mice
KW  - Mice, Nude
KW  - Neoplasm Proteins
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-myb
KW  - Pyrimidines
KW  - RNA, Small Interfering
KW  - Recombinant Proteins
KW  - TNF-Related Apoptosis-Inducing Ligand
KW  - Thiazoles
KW  - Tumor Suppressor Protein p53
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/0008-5472.CAN-11-1383
ER  -